Annual Cash & Cash Equivalents
$618.83 M
-$91.58 M-12.89%
December 31, 2023
Summary
- As of February 8, 2025, PRTA annual cash & cash equivalents is $618.83 million, with the most recent change of -$91.58 million (-12.89%) on December 31, 2023.
- During the last 3 years, PRTA annual cash & cash equivalents has risen by +$323.45 million (+109.50%).
- PRTA annual cash & cash equivalents is now -12.89% below its all-time high of $710.41 million, reached on December 31, 2022.
Performance
PRTA Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$519.26 M
-$44.86 M-7.95%
September 30, 2024
Summary
- As of February 8, 2025, PRTA quarterly cash and cash equivalents is $519.26 million, with the most recent change of -$44.86 million (-7.95%) on September 30, 2024.
- Over the past year, PRTA quarterly cash and cash equivalents has dropped by -$99.57 million (-16.09%).
- PRTA quarterly cash and cash equivalents is now -26.91% below its all-time high of $710.41 million, reached on December 31, 2022.
Performance
PRTA Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
PRTA Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -12.9% | -16.1% |
| 3 y3 years | +109.5% | -13.5% |
| 5 y5 years | +44.7% | +33.0% |
PRTA Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -12.9% | +6.9% | -26.9% | +4.8% |
| 5 y | 5-year | -12.9% | +109.5% | -26.9% | +75.8% |
| alltime | all time | -12.9% | -100.0% | -26.9% | +409.8% |
Prothena Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $519.26 M(-8.0%) |
| Jun 2024 | - | $564.12 M(+3.2%) |
| Mar 2024 | - | $546.51 M(-11.7%) |
| Dec 2023 | $618.83 M(-12.9%) | $618.83 M(-7.8%) |
| Sep 2023 | - | $670.90 M(+1.8%) |
| Jun 2023 | - | $659.11 M(-3.9%) |
| Mar 2023 | - | $686.18 M(-3.4%) |
| Dec 2022 | $710.41 M(+22.7%) | $710.41 M(+43.3%) |
| Sep 2022 | - | $495.63 M(-2.6%) |
| Jun 2022 | - | $508.80 M(-6.3%) |
| Mar 2022 | - | $542.99 M(-6.2%) |
| Dec 2021 | $579.09 M(+96.1%) | $579.09 M(-3.5%) |
| Sep 2021 | - | $600.10 M(+50.1%) |
| Jun 2021 | - | $399.83 M(+16.6%) |
| Mar 2021 | - | $342.99 M(+16.1%) |
| Dec 2020 | $295.38 M(-21.4%) | $295.38 M(-6.1%) |
| Sep 2020 | - | $314.52 M(-5.8%) |
| Jun 2020 | - | $333.94 M(-5.3%) |
| Mar 2020 | - | $352.69 M(-6.1%) |
| Dec 2019 | $375.72 M(-12.1%) | $375.72 M(-3.7%) |
| Sep 2019 | - | $390.30 M(-2.0%) |
| Jun 2019 | - | $398.14 M(-2.9%) |
| Mar 2019 | - | $410.11 M(-4.1%) |
| Dec 2018 | $427.66 M | $427.66 M(-5.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | $451.51 M(-7.1%) |
| Jun 2018 | - | $486.21 M(+13.3%) |
| Mar 2018 | - | $429.04 M(+2.7%) |
| Dec 2017 | $417.62 M(+7.9%) | $417.62 M(-8.4%) |
| Sep 2017 | - | $456.06 M(-3.3%) |
| Jun 2017 | - | $471.73 M(-6.9%) |
| Mar 2017 | - | $506.55 M(+30.9%) |
| Dec 2016 | $386.92 M(+4.4%) | $386.92 M(-5.3%) |
| Sep 2016 | - | $408.57 M(-7.8%) |
| Jun 2016 | - | $442.95 M(-6.6%) |
| Mar 2016 | - | $474.25 M(+28.0%) |
| Dec 2015 | $370.59 M(+26.2%) | $370.59 M(-4.4%) |
| Sep 2015 | - | $387.80 M(-3.6%) |
| Jun 2015 | - | $402.39 M(+43.8%) |
| Mar 2015 | - | $279.86 M(-4.7%) |
| Dec 2014 | $293.58 M(+66.2%) | $293.58 M(-4.1%) |
| Sep 2014 | - | $306.15 M(+0.8%) |
| Jun 2014 | - | $303.85 M(+55.8%) |
| Mar 2014 | - | $195.05 M(+10.4%) |
| Dec 2013 | $176.68 M(+41.5%) | $176.68 M(+73.5%) |
| Sep 2013 | - | $101.86 M(-9.5%) |
| Jun 2013 | - | $112.51 M(-5.9%) |
| Mar 2013 | - | $119.56 M(-4.2%) |
| Dec 2012 | $124.86 M(>+9900.0%) | $124.86 M |
| Dec 2011 | $0.00 | - |
FAQ
- What is Prothena annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Prothena?
- What is Prothena annual cash & cash equivalents year-on-year change?
- What is Prothena quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Prothena?
- What is Prothena quarterly cash and cash equivalents year-on-year change?
What is Prothena annual cash & cash equivalents?
The current annual cash & cash equivalents of PRTA is $618.83 M
What is the all time high annual cash & cash equivalents for Prothena?
Prothena all-time high annual cash & cash equivalents is $710.41 M
What is Prothena annual cash & cash equivalents year-on-year change?
Over the past year, PRTA annual cash & cash equivalents has changed by -$91.58 M (-12.89%)
What is Prothena quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of PRTA is $519.26 M
What is the all time high quarterly cash and cash equivalents for Prothena?
Prothena all-time high quarterly cash and cash equivalents is $710.41 M
What is Prothena quarterly cash and cash equivalents year-on-year change?
Over the past year, PRTA quarterly cash and cash equivalents has changed by -$99.57 M (-16.09%)